Crownbio – cancer Immunotherapy and xenograft models

Crownbio provides a “gold-standard” collection of well-characterized models and services for drug discovery to help its clients reduce the attrition rate of candidate compounds, before they enter the clinic.

Crownbio – cancer Immunotherapy and xenograft models

 crownbio Continue reading

Nerviano – antibody drug conjugate

Nerviano is a biotech company identifying innovative agents for clinical development in areas of unmet medical needs in Oncology.

Nerviano – antibody drug conjugate

Nerviano Continue reading

Selvita – accelerating drug discovery

Selvita is a biotech company offering drug discovery support at every step of the process, from the early discovery phase up to preclinical research. Selvita delivers a comprehensive panel of solutions to accelerate and decrease the cost of the introduction of new drugs to the market.

Selvita – accelerating drug discovery

selvita Continue reading

OncoDNA – deep sequencing of tumor DNA

OncoDNA is the first European company to provide personalized medicine in oncology based on the analysis of patient tumor DNA.

OncoDNA – deep sequencing of tumor DNA

oncoDNA Continue reading

ActivX – in situ kinase profiling

ActivX is a biotech company developing activity-based profiling systems for several families of drug targets (including kinases and serine hydrolases). The utility of these probes in facilitating drug discoveries has been validated for multiple therapeutic areas including metabolic diseases, oncology and pain management.

ActivX – in situ kinase profiling

Activx

Continue reading